Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer
MetadataShow full item record
Volpato , M , Cummings , M , Shaaban , A M , Abderrahman , B , Hull , M A , Maximov , P Y , Broom , B M , Hoppe , R , Fan , P , Brauch , H , Jordan , V C & Speirs , V 2020 , ' Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer ' , Exploration of Targeted Anti-tumor Therapy , vol. 1 , pp. 355-371 . https://doi.org/10.37349/etat.2020.00021
This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.